Rapid action insulin formulations and pharmaceutical delivery systems
US10561711B2 · kind B2 · utility
1Cited by
15References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 12, 2018 |
| Grant date | Feb 18, 2020 |
| Priority date | — |
| Expiry date | Jan 12, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M2230/201
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides rapid-acting insulin and insulin analogue formulations. The invention further provides delivery devices, particularly infusion sets, which allow for the rapid absorption of insulin and insulin analogues, as well as other active agents. Methods of using the insulin and insulin analogue formulations as well as the insulin delivery devices for treating subjects with diabetes mellitus are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.